Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MNOV
STRONG SELLMediciNova, Inc. · Healthcare · United States · $65M · Avg Vol: $87K/d
14
StockRankGet insider-trade alerts
Q
32
V
30
M
33
P/E (TTM)
—
ROE
-26.2%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)+7.3%
SMA 50SMA 200
Close
$1.32
RSI (14)
28.6
52W High
$1.96
From 52W High
0.7%
SCORE BREAKDOWN
Quality
32
ROIC
-30.9%24.2
ROE
-26.2%28.6
GP/Assets
0.1%11.2
Op. Margin
-1516.6%5.9
FCF/Assets
-21.5%17.2
Piotroski
239.0
Int. Cover
—N/A
D/E Ratio
0.00x89.4
Current Ratio
9.09x84.6
Value
30
P/E (TTM)
—N/A
EV/EBITDA
-2.9x25.0
P/FCF
—N/A
P/B
1.6x67.9
P/S
108.9x7.3
Div Yield
—N/A
Momentum
33
52W High %
67%50.2
RS 6M
-37%24.5
SMA 50/200
0.95x53.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
-87%5.6
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$65M
P/E (Forward)
-3.1x
Gross Margin
8.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MNOV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MNOV | MediciNova, Inc.(you) | $65M | 14 | STRONG SELL |
| ACRV | Acrivon Therapeutics, Inc. | $68M | 14 | STRONG SELL |
| OSTX | OS Therapies Incorporated | $68M | 16 | STRONG SELL |
| FLNA | Filana Therapeutics, Inc. | $58M | 13 | STRONG SELL |
| IMA | ImageneBio, Inc. | $63M | 11 | STRONG SELL |
| CING | Cingulate Inc. | $62M | 11 | STRONG SELL |
| PLRX | Pliant Therapeutics, Inc. | $67M | 18 | STRONG SELL |
| MAIA | MAIA Biotechnology, Inc. | $75M | 12 | STRONG SELL |
| KALA | KALA BIO, Inc. | $63M | 9 | STRONG SELL |
| HYFT | MindWalk Holdings Corp. | $64M | 8 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.7%